Takeda To Pay $13.6M Over Antidepressant Drug Kickbacks
By Gina Kim · May 14, 2026, 9:43 PM EDT
Takeda Pharmaceuticals will pay $13.6 million to end allegations that it caused false Medicaid claims by providing kickbacks to healthcare providers to push prescriptions of its antidepressant drug Trintellix, the U.S. Department...
To view the full article, register now.